Cabaletta Bio, Inc. (CABA)
3.17
-0.01
(-0.31%)
USD |
NASDAQ |
Mar 06, 16:00
3.20
+0.03
(+0.95%)
After-Hours: 20:00
Cabaletta Bio EPS Diluted (Quarterly) : -0.4387 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | -0.0638 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.87M |
| Total Expenses (Quarterly) | 44.87M |
| Enterprise Value | 171.01M |
| Earnings Yield | -79.69% |
| Normalized Earnings Yield | -79.70 |